Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PDE2A antisense RNA 2 (PDE2A-AS2)
- Target
- PDE2A-AS2
- Molecular classification
- long non-coding RNA, antisense RNA
01
Overview
PDE2A antisense RNA 2 (PDE2A-AS2) is a long non-coding antisense RNA transcribed from the region opposite to the phosphodiesterase 2A (PDE2A) gene. It does not encode a protein and is not recognized as a receptor, enzyme, transporter, or other canonical therapeutic target. As of current knowledge, there is minimal information on its biological function, disease association, or direct clinical applications. Most literature and databases focus on the protein-coding gene PDE2A, which is a well-characterized phosphodiesterase involved in cAMP and cGMP signaling, but not on its antisense RNAs[1][2][3][4][5][6][7].
- Other names
- PDE2A-AS2PDE2A antisense RNA 2
Beyond the preview
Go deeper on PDE2A antisense RNA 2 (PDE2A-AS2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PDE2A antisense RNA 2 (PDE2A-AS2).